These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7490789)
61. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481 [TBL] [Abstract][Full Text] [Related]
62. Toxicology and carcinogenesis studies of N,N-dimethyl-p-toluidine (CAS No. 99-97-8) in F344/N rats and B6C3F1/N mice (gavage studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2012 Sep; (579):1-211. PubMed ID: 23027199 [TBL] [Abstract][Full Text] [Related]
64. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS No. 7487-94-7) in F344 Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Feb; 408():1-260. PubMed ID: 12621522 [TBL] [Abstract][Full Text] [Related]
65. A novel contrast-induced acute kidney injury model based on the 5/6-nephrectomy rat and nephrotoxicological evaluation of iohexol and iodixanol in vivo. Liu TQ; Luo WL; Tan X; Fang Y; Chen J; Zhang H; Yu XF; Cai JR; Ding XQ Oxid Med Cell Longev; 2014; 2014():427560. PubMed ID: 25478060 [TBL] [Abstract][Full Text] [Related]
66. Species and sex differences in susceptibility to olfactory lesions among the mouse, rat and monkey following an intravenous injection of vincristine sulphate. Kai K; Sahto H; Yoshida M; Suzuki T; Shikanai Y; Kajimura T; Furuhama K Toxicol Pathol; 2006; 34(3):223-31. PubMed ID: 16698718 [TBL] [Abstract][Full Text] [Related]
67. Ioglucomide: a new nonionic myelographic agent. Preclinical studies. Hopkins RM; Adams MD; Lau DH; Creighton JM; Hoey GB Radiology; 1981 Sep; 140(3):713-7. PubMed ID: 7280240 [TBL] [Abstract][Full Text] [Related]
68. Effects of viscosity on power and hand injection of iso-osmolar iodinated contrast media through thin catheters. Zhang JJ; Hogstrom B; Malinak J; Ikei N Acta Radiol; 2016 May; 57(5):557-64. PubMed ID: 26185266 [TBL] [Abstract][Full Text] [Related]
69. Adverse skin reactions to iodinated x-ray contrast agents in healthy rats. Lenhard DC; May E; Morgenroth C; Jost G; Haider W; Pietsch H Invest Radiol; 2014 Dec; 49(12):779-87. PubMed ID: 24988006 [TBL] [Abstract][Full Text] [Related]
70. Preclinical safety assessment of Vasovist (Gadofosveset trisodium), a new magnetic resonance imaging contrast agent for angiography. Steger-Hartmann T; Graham PB; Müller S; Schweinfurth H Invest Radiol; 2006 May; 41(5):449-59. PubMed ID: 16625108 [TBL] [Abstract][Full Text] [Related]
71. Iodinated starch particles: new contrast material for computed tomography of the liver. Cohen Z; Seltzer SE; Davis MA; Hanson RN J Comput Assist Tomogr; 1981 Dec; 5(6):843-6. PubMed ID: 7320289 [TBL] [Abstract][Full Text] [Related]
72. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease. Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975 [TBL] [Abstract][Full Text] [Related]
73. NTP Toxicology and Carcinogenesis Studies of d-Limonene (CAS No. 5989-27-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1990 Jan; 347():1-165. PubMed ID: 12704437 [TBL] [Abstract][Full Text] [Related]
74. Systemic, pulmonary and renal haemodynamic and renal morphologic effects of intravenously infused iodixanol. A study in the pig of a new iso-osmolar contrast medium. Sunnegårdh O; Hietala SO; Holtz E Acta Radiol; 1990 Sep; 31(5):513-8. PubMed ID: 2261302 [TBL] [Abstract][Full Text] [Related]
75. Comparative effects of ionic and nonionic iodinated low-osmolar contrast media on platelet function with the PFA-100 (platelet function analyzer). D'Anglemont De Tassigny A; IDéE JM; Corot AC Invest Radiol; 2001 May; 36(5):276-82. PubMed ID: 11323515 [TBL] [Abstract][Full Text] [Related]
76. Contrast media: quantitative criteria for designing compounds with low toxicity. Levitan H; Rapoport SI Acta Radiol Diagn (Stockh); 1976 Jan; 17(1):81-92. PubMed ID: 1266659 [TBL] [Abstract][Full Text] [Related]
77. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232 [TBL] [Abstract][Full Text] [Related]
78. Tissue reaction follwing intratracheal application of roentgen contrast media in rats. Larsen LE; Grant D; Walday P Acta Radiol Suppl; 1995; 399():258-61. PubMed ID: 8610525 [TBL] [Abstract][Full Text] [Related]
79. [Oral single-dose and 13-week repeat-dose toxicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in rats]. Furukawa S; Kouyama H; Kikumori M; Taniguchi Y; Nishimori T; Ishibashi S; Iwakura K; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():93-124. PubMed ID: 9170604 [TBL] [Abstract][Full Text] [Related]